Modified Nucleotides
N1-Methylpseudouridine-5'-Triphosphate
Quick view. N1-Methylpseudouridine-5'-Triphosphate is a modified uridine triphosphate for research-use nucleotide chemistry. CAS 1428903-59-6. Catalog target purity: ≥99%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
N1-Methylpseudouridine-5'-Triphosphate is classified as modified nucleoside triphosphate (Formula C10H17N2O15P3; molecular weight 498.17).
N1-Methylpseudouridine-5'-Triphosphate — Modified uridine triphosphate reagent for research workflows that specify the counterion-free N1-methylpseudouridine form.
For N1-Methylpseudouridine-5'-Triphosphate, modification benefits are context-dependent; transcript length, substitution level, enzyme system and analytical purity can change the observed outcome.
Names and search terms
Confirmed or normalized name variants
- N1-Methylpseudo-UTP
- m1Psi-5'-Triphosphate
Useful catalog search terms
- CAS 1428903-59-6
Physicochemical data
| Counterion | None in the controlling representation |
|---|---|
| PubChem CID | 90456815 |
| InChI | InChI=1S/C10H17N2O15P3/c1-12-2-4(9(15)11-10(12)16)8-7(14)6(13)5(25-8)3-24-29(20,21)27-30(22,23)26-28(17,18)19/h2,5-8,13-14H,3H2,1H3,(H,20,21)(H,22,23)(H,11,15,16)(H2,17,18,19)/t5-,6-,7-,8+/m1/s1 |
| InChIKey | OLRONOIBERDKRE-XUTVFYLZSA-N |
| SMILES | CN1C=C(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Product-specific evaluation notes
Potential advantages
- Base modifications can tune RNA stability, translation behavior, duplex properties or analytical discrimination versus native bases.
Method limitations
- Modification benefits are context-dependent; transcript length, substitution level, enzyme system and analytical purity can change the observed outcome.
These points describe N1-Methylpseudouridine-5'-Triphosphate or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
3'-OMe-GDP Disodium Salt
Modified Nucleotides · CAS: N/A
BX-INTE-00143'-OMe-GMP
Modified Nucleotides · CAS: 400806-41-9
BX-INTE-00153'-OMe-GMP TEA Salt
Modified Nucleotides · CAS: 860605-85-2
BX-INTE-0021Im-3'-OMe-GMP
Modified Nucleotides · CAS: 1005791-93-4
BX-INTE-0023Im-GDP
Modified Nucleotides · CAS: 1199264-75-9
BX-MN-0025(-)-Emtricitabine Triphosphate Tetrasodium Salt
Modified Nucleotides · CAS: 1188407-46-6
Frequently asked questions
Can the package size for N1-Methylpseudouridine-5'-Triphosphate be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-GSS-0046 and CAS 1428903-59-6, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-relevant literature
The publications below discuss named chemistry or a structural feature represented by this product. They provide scientific context only and are not a BX Lab lot specification or product-performance claim.
- Human adipose-derived multipotent stromal cells enriched with IL-10 modRNA improve diabetic wound healing: Trigger the macrophage phenotype shift. (2025)
- Development of a retention prediction model in ion-pair reversed-phase HPLC for nucleoside triphosphates used as mRNA vaccine raw materials. (2022)
- Optimizing Cardiac Delivery of Modified mRNA. (2017)
Feature and workflow background
These publications discuss a broader chemistry feature or workflow identified from the catalog name or product family. They are background reading only, not evidence for the exact BX Lab product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.